We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+13.57%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$21.2B
AUM Growth
+$2.31B
(+12%)
Cap. Flow
+$622M
Cap. Flow
% of AUM
2.93%
Top 10 Holdings %
Top 10 Hldgs %
15.94%
Holding
1,089
New
178
Increased
395
Reduced
238
Closed
219
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chubb
CB
|
+$215M |
| 2 |
AT&T
T
|
+$206M |
| 3 |
Keysight
KEYS
|
+$199M |
| 4 |
Amazon
AMZN
|
+$154M |
| 5 |
NXP Semiconductors
NXPI
|
+$149M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$224M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
+$216M |
| 3 |
Teradyne
TER
|
+$137M |
| 4 |
Brown & Brown
BRO
|
+$120M |
| 5 |
Arthur J. Gallagher & Co
AJG
|
+$116M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.42% |
| 2 | Healthcare | 23.84% |
| 3 | Financials | 10.35% |
| 4 | Consumer Discretionary | 9.93% |
| 5 | Industrials | 7.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RNAM
351
DELISTED
Avidity Biosciences
RNAM
| $14.1M | 0.07% |
323,774
-311,320
| -49% | -$12.6M |
|
352
Repligen
RGEN
$9B
| $14.1M | 0.07% |
105,449
+95,181
| +927% | +$11.6M |
|
353
Genmab
GMAB
$18.3B
| $14.1M | 0.07% |
459,176
-34,330
| -7% | -$837K |
|
354
Kymera Therapeutics
KYMR
$8.85B
| $14M | 0.07% |
248,000
-250,111
| -50% | -$11.3M |
|
355
Lennox International
LII
$15.1B
| $14M | 0.07% |
26,514
-50,781
| -66% | -$29.7M |
|
356
Nutanix
NTNX
$16.3B
| $14M | 0.07% |
+187,584
| New | +$13.8M |
|
357
Corebridge Financial
CRBG
$15.2B
| $13.9M | 0.07% |
433,130
-122,870
| -22% | -$4.2M |
|
|
SPNS
358
DELISTED
Sapiens International
SPNS
| $13.8M | 0.07% |
+322,000
| New | +$11.7M |
|
359
Albemarle
ALB
$14.8B
| $13.8M | 0.07% |
170,476
+157,765
| +1,241% | +$12.2M |
|
360
Southern Company
SO
$107B
| $13.8M | 0.06% |
145,384
+26,501
| +22% | +$2.47M |
|
361
Mettler-Toledo International
MTD
$28.5B
| $13.8M | 0.06% |
11,222
-4,598
| -29% | -$5.76M |
|
362
Outfront Media
OUT
$5.48B
| $13.7M | 0.06% |
+748,087
| New | +$13.6M |
|
363
Ferrari
RACE
$71.6B
| $13.7M | 0.06% |
+28,241
| New | +$13.5M |
|
|
AVDL
364
DELISTED
Avadel Pharmaceuticals
AVDL
| $13.7M | 0.06% |
897,086
| – | – |
|
365
Constellation Energy
CEG
$93.2B
| $13.6M | 0.06% |
41,288
+7,386
| +22% | +$2.38M |
|
366
Biogen
BIIB
$30.5B
| $13.5M | 0.06% |
96,666
+1,106
| +1% | +$150K |
|
367
Carpenter Technology
CRS
$27.7B
| $13.5M | 0.06% |
55,050
+27,395
| +99% | +$7.01M |
|
368
MP Materials
MP
$8.45B
| $13.4M | 0.06% |
+200,000
| New | +$12.6M |
|
369
Element Solutions
ESI
$9.37B
| $13.4M | 0.06% |
530,863
+57,034
| +12% | +$1.42M |
|
|
ARIS
370
Aris Mining
ARIS
$3.25B
| $13.4M | 0.06% |
+1,363,415
| New | +$10.9M |
|
371
Align Technology
ALGN
$12B
| $13.3M | 0.06% |
106,373
+2,345
| +2% | +$367K |
|
372
Beam Therapeutics
BEAM
$2.81B
| $13.3M | 0.06% |
546,559
-214,939
| -28% | -$4.28M |
|
373
Nektar Therapeutics
NKTR
$2.48B
| $13.3M | 0.06% |
233,059
-13,086
| -5% | -$433K |
|
374
H&R Block
HRB
$5.82B
| $13.2M | 0.06% |
+260,532
| New | +$13.8M |
|
|
MRSH
375
Marsh
MRSH
$92.2B
| $13.1M | 0.06% |
+64,974
| New | +$13.4M |
|
Similar funds
TCIIS
UIM
VAI
KK
Woodline Partners's Q3 2025 Portfolio in Review
As of Q3 2025, Woodline Partners held 1,089 positions worth $21.2B, up 12% from $18.9B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Woodline Partners's Q3 2025 filing shows 178 new, 395 increased, 238 reduced and 219 closed positions. Its largest new stake was Chubb: 780,221 shares worth $220M. The largest sale was Meta Platforms (Facebook), an estimated $224M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
- Woodline Partners's largest Q3 2025 buy was Chubb: 780,221 shares worth $220M.
- Woodline Partners added most to AT&T in Q3 2025, an estimated $206M increase.
- Woodline Partners's biggest Q3 2025 reduction was Meta Platforms (Facebook), cutting an estimated $224M.
- Woodline Partners fully exited Brown & Brown in Q3 2025, selling an estimated $120M.
- Woodline Partners's ten largest holdings make up 16% of its $21.2B portfolio in Q3 2025.
- Woodline Partners opened 178 new positions and closed 219 in Q3 2025.
- Woodline Partners's portfolio value rose 12% quarter-over-quarter to $21.2B.
Based on Woodline Partners's 13F filing for Q3 2025, filed 14 Nov 2025.